GlassScriptPhysician profile
Tesia Mckenzie
NPI 1205325024
$2,869.17
in general payments reported to CMS, 2019-2025
8 companies · $718 in 2025
The $718 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $689 · 2024: $1,462 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,859 · Travel and Lodging: $9.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,859.21 |
| Travel and Lodging | $9.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics LTD | $1,338.31 | 2023-2024 | Magseed, Magtrace |
| Davol INC. | $642.32 | 2024-2025 | Phasix Mesh, Bard 3dmax Mesh, Arista |
| Hologic Sales and Service, LLC | $400.09 | 2025 | Coolseal Generator, Magseed |
| Leica Microsystems INC. | $190.00 | 2023 | |
| Gilead Sciences, INC. | $125.00 | 2024 | Trodelvy |
| Merit Medical Systems INC | $105.86 | 2024 | Savi Scout |
| Becton, Dickinson and Company | $46.08 | 2024 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $21.51 | 2025 | Lynparza, Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tesia Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.